SUIVIPROCHE: Sudden Death Counselling and Its Impact on Family Members of Sudden Death Victims

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Recruiting
CT.gov ID
NCT03320902
Collaborator
INSERM U970 (Other)
620
1
2
63.9
9.7

Study Details

Study Description

Brief Summary

Assessment of the psychological benefit of the proposition by prehospital medical team of a sudden death counselling on family members of sudden death victims.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Sudden death counselling
N/A

Detailed Description

Family members are often shocked and devastated by the death of their loved one, especially when it is sudden and unexpected. On the scene, families often don't really believe it happened because they didn't have time to absorb the fact of their loss. They hear the words and explanation given by the prehospital emergency medical services (EMS) team, but do not comprehend the full impact. Emotions seem frozen. They feel disoriented, restless, stunned and unable to think.

Most often, after cardiac arrest resuscitation attempt, the prehospital EMS team leaves the scene, letting the family without any further medical bond and support. Families are left alone facing this tragedy. After a while, families need medical counseling trying to understand what happens and why but they don't know who to consult. Instead, they remain without medical explanation or guidance with the fear regarding their own future, in particular, regarding the risk of dying from sudden death. This fear may be based on the knowledge of the eventuality of familial diseases increasing the risk of sudden death, or simply on a mechanism of identification with the deceased.

One important factor credited by experts is to encourage first-degree family members to seek sudden death counselling. However, the literature concerning this problem lacks of reliable data.

The aim of this clinical trial is to evaluate the psychological consequences of a sudden death counselling on family member after a relative's sudden death compared to the usual family management.

This study will compare the percentage of depression in a group of family members after a relative's sudden death for whom a sudden death counselling has been proposed by the prehospital medical team versus a group for whom the medical team has not modified its usual strategy.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
620 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Sudden Death Counselling and Its Impact on Family Members of Sudden Death Victims
Actual Study Start Date :
Jan 18, 2018
Anticipated Primary Completion Date :
Jan 18, 2023
Anticipated Study Completion Date :
May 18, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Sudden death counselling

The emergency physician of the prehospital EMS who intervenes at the scene will systematically give the family member allocated to the intervention the option to attend a sudden death counselling during the first month after the event.

Behavioral: Sudden death counselling
The Sudden Death Counselling with included relatives at 1 month (+/-15 days) after the eventafter the event will be at the Europeen Georges Pompidou hospital in Paris. The purpose of this Sudden Death Counselling is to provide to family members of sudden death victims information, support, referral and follow-up services relating to sudden death and their grief, if needed. The bereaved people will tell their experience. The Sudden Death Counselling would help them to integrate life's losses by companioning them. Cardiologist and psychologists will be present to listen to their pain and try to bring comfort by answering to their questionings.

No Intervention: Usual practice

The physician will act as usual. The relatives will not systematically benefit from this option.

Outcome Measures

Primary Outcome Measures

  1. Hospital Anxiety and Depression Scale, sub-section Depression (HADSD) >10 [at 3 months from the sudden death]

    Percentage of relatives with moderate to severe symptoms of depression evaluated by the 'Hospital Anxiety and Depression Scale' score, subscale Depression (HADSD) >10

  2. Hospital Anxiety and Depression Scale, sub-section Anxiety (HADSA) >10 [At 3 months from the sudden death]

    Percentage of relatives with moderate to severe symptoms of anxiety evaluated by the 'Hospital Anxiety and Depression Scale' score, subscale Anxiety (HADSA) >10

Secondary Outcome Measures

  1. Impact of Event Scale-revised score (IES-R) ≥ 33 [at 3 months from the sudden death]

    Percentage of relatives with symptoms of post-traumatic stress disorder evaluated by the 'Impact of Event Scale' score (IES-R) ≥ 33

  2. Medical Outcome Study Short Form Health Survey (SF-12) [At 3 months from the sudden death]

    Quality of life questionnaire : the SF-12 is the 12 item abbreviated form of SF-36 survey. It provides information about how participants feel, and how well they have been able to perform their usual activities. SF-12 questions make up 8 scales: Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, Mental Health . Transformed physical component summary score (PCS) and transformed mental component summary score (MCS) are derived using the sum of all 12 items and scored onto a 0-100 scale such that a higher score indicates a better health state and better functioning.

  3. Visits number to the general physician [At 3 months from the sudden death]

  4. Drug use [At 3 months from the sudden death]

  5. Visits number to the psychologist and/or psychiatrist [At 3 months from the sudden death]

  6. Relatives number integrating a grief recovery support group [At 3 months from the sudden death]

    Number of participants that have integrated a grief recovery support group

  7. Feeling of the sudden death consultation or not by the relatives [At 3 months from the sudden death]

  8. Proportion of identified causes of sudden death [At 3 months from the sudden death]

  9. Proportion of familial screening [At 3 months from the sudden death]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
A first-degree relative of a:
  • patient aged 18-75 years

  • with an out-of-hospital sudden death*

  • and cardiopulmonary resuscitation attempted Relative aged ≥ 18 years Given consent for the study. Sudden death definition*: An unexpected cardiac arrest without obvious extracardiac cause, leading to a collapse in front of a witness (or in the absence of witnesses, occurring within the hour after the onset of symptoms).

Exclusion Criteria:

Relative under guardianship/curatorship Relative unable to communicate Relative not affiliated to a medical insurance

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Necker-Enfants malades Paris France 75015

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris
  • INSERM U970

Investigators

  • Principal Investigator: Patricia JABRE, MD, PhD, Assistance Publique - Hôpitaux de Paris

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT03320902
Other Study ID Numbers:
  • K160905
  • 2017-A0098-45
First Posted:
Oct 25, 2017
Last Update Posted:
Jan 25, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Assistance Publique - Hôpitaux de Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 25, 2022